Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness
Purpose. To report on an improved botulinum toxin injection with conjunctival microincision for beginners, and to determine the effectiveness of botulinum toxin A (BTXA) in the treatment of patients with acute acquired comitant esotropia (AACE). Methods. Medical records of 29 AACE patients were retr...
Saved in:
Main Authors: | Hongjia Xu, Weifeng Sun, Shuying Dai, Yanyan Cheng, Jing Zhao, Yuan Liu, Juan Wang, Ya’nan Wang, Yu Gao, Huifang Han, Aijun Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2020/1702695 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botulinum toxin A as a treatment modality for acute acquired comitant esotropia – An Indian perspective
by: Akshay Badakere, et al.
Published: (2025-02-01) -
Botulinum toxin-A in acute acquired comitant esotropia during COVID pandemic in children and young adolescents
by: Neelam Pawar, et al.
Published: (2025-02-01) -
Acute Acquired Comitant Esotropia in Adults: Is It Neurologic or Not?
by: Kadriye Erkan Turan, et al.
Published: (2016-01-01) -
Acute acquired comitant esotropia in the era of the COVID-19 pandemic
by: Ali Nouraeinejad
Published: (2024-03-01) -
Reply to “Acute acquired comitant esotropia in the era of the COVID-19 pandemic”
by: Piotr Loba
Published: (2024-03-01)